Having trouble viewing this message? View this email in a browser.
Share Share
Tweet Tweet
Forward Forward

Asthma Resources for Schools During the COVID-19 Pandemic

Schools that are required to reopen in the fall face new challenges trying to teach while preventing the spread of the new coronavirus. Tactics to prevent the spread of the virus that causes COVID-19 may impact staff and students with asthma. AAFA has created a COVID-19 and Asthma Toolkit for Schools to provide supplemental guidance to assist schools as they develop their policies and procedures.

Expert Advice: Face Masks/Coverings and Asthma

Face coverings are an important part of our fight against the new coronavirus. But how do face coverings and masks affect people with asthma? What are the best options for people with asthma, especially if your job requires them? We answer many of the questions you may have concerning asthma and face coverings or masks.

Bridging the Gap In Racial Disparities

Black, Hispanic and Indigenous Americans experience higher rates of asthma and COVID-19. AAFA has always been dedicated with our work toward striving for justice in fighting to reduce disparities in care for underserved groups. We’re working hard to keep these issues at the forefront. Read about our current efforts to fight racial disparities in people with asthma and allergic diseases. We will soon be releasing a 15-year review on asthma disparities to follow up our often-quoted 2005 report on racial and ethnic disparities in asthma.

How Do Products Get CERTIFIED asthma & allergy friendly®?

Products that are CERTIFIED asthma & allergy friendly® are independently tested against strict standards approved by AAFA. Only products that pass every test will earn the certification. Not all products pass the tests. The CERTIFIED mark helps you make informed decisions when creating a healthier home. Learn more about our Certification process.


Now more than ever people with asthma and allergies need our help. As COVID-19 continues to spread, we face a crisis. It won't improve unless we all work together.

With your help, we provide education and support, conduct patient-centered research and advocate for protections for our asthma and allergy communities. These efforts help save lives and improve quality of life for people with asthma and allergies.

Due to the pandemic, we have had to cancel our major fundraisers of the year. This puts our life-saving programs at risk. Can we count on your support to help keep our programs fully operational?




FDA Clarifies Temporary Food Labeling Guidelines

In May, the Food and Drug Administration (FDA) made temporary changes to food labeling guidelines. This raised many questions for people with food allergies. AAFA and other organizations sent a letter to the FDA about the guidelines. The FDA responded.

FDA Approves Dupilumab for Children 6 to 11 With Atopic Dermatitis

Dupilumab (Dupixent®) may now be used to treat children 6 to 11 with moderate-to-severe atopic dermatitis. See the press release for more information.


Knowing how to manage severe asthma is important for better health and quality of life. We offer an online course called Severe ASTHMA Care for Adults. This self-paced program covers a full range of topics everyone with severe asthma needs to know: medicine options, work accommodations, emotional health and more.


AsthmaCon, a Virtual Asthma Conference

Learn about asthma management from top experts and patients at AsthmaCon, a virtual asthma conference now through July 31, 2020. You can attend sessions on asthma symptoms, diet and exercise, severe asthma, research, treatments and more. Also visit AAFA's booths in the virtual exhibit hall for educational videos and printable handouts on asthma management and creating a healthier home!

Thank you for your continued support.

Follow Follow
Twitter Twitter
Instagram Instagram
Disclaimer: This newsletter is provided to you as a member and subscriber benefit and your use of it is in accordance with our website's terms of service.

Asthma and Allergy Foundation of America makes no representation, whatsoever, for the contents that may be contained in any of the sponsors or advertisers in this newsletter or the quality of any products, information, or other materials displayed, purchased or obtained by you as a result of an offer in connection with any advertisement. 

Please follow the instructions at the bottom of the newsletter to unsubscribe if you no longer wish to be on our newsletter mailing list. This newsletter is sent to all newsletter subscribers, registered members and donors of Asthma and Allergy Foundation of America.

Copyright © 2020 Asthma and Allergy Foundation of America, All rights reserved. ISSN 1939-8166.